Differential activity by polymorphic variants of a remote enhancer that supports galanin expression in the hypothalamus and amygdala: implications for obesity, depression and alcoholism
about
Neurobiology of adolescent substance use and addictive behaviors: treatment implicationsExploring the effects of polymorphisms on cis-regulatory signal transduction responseEffects of negative stressors on DNA methylation in the brain: implications for mood and anxiety disordersAn evaluation of a SVA retrotransposon in the FUS promoter as a transcriptional regulator and its association to ALSAlteration of behavioral changes and hippocampus galanin expression in chronic unpredictable mild stress-induced depression rats and effect of electroacupuncture treatmentEvaluating the role of a galanin enhancer genotype on a range of metabolic, depressive and addictive phenotypes.Determining Epigenetic Targets: A Beginner's Guide to Identifying Genome Functionality Through Database Analysis.Allele-specific differences in activity of a novel cannabinoid receptor 1 (CNR1) gene intronic enhancer in hypothalamus, dorsal root ganglia, and hippocampus.Changes in Galanin Systems in a Rat Model of Post-Traumatic Stress Disorder (PTSD)Adaptation of the targeted capture Methyl-Seq platform for the mouse genome identifies novel tissue-specific DNA methylation patterns of genes involved in neurodevelopmentThe evolutionary significance of depression in Pathogen Host Defense (PATHOS-D).Distinct features of neurotransmitter systems in the human brain with focus on the galanin system in locus coeruleus and dorsal raphe.Regulation of neurological and neuropsychiatric phenotypes by locus coeruleus-derived galanin.A polymorphism associated with depressive disorders differentially regulates brain derived neurotrophic factor promoter IV activity.Analysis of the effects of depression associated polymorphisms on the activity of the BICC1 promoter in amygdala neuronesBiological contributions to addictions in adolescents and adults: prevention, treatment, and policy implications.Galanin's implications for post-stroke improvement.Brain galanin system genes interact with life stresses in depression-related phenotypes.Understanding the Dynamics of Gene Regulatory Systems; Characterisation and Clinical Relevance of cis-Regulatory Polymorphisms.The noncoding human genome and the future of personalised medicine.Galanin receptors as a potential target for neurological disease.Identification and Potential Regulatory Properties of Evolutionary Conserved Regions (ECRs) at the Schizophrenia-Associated MIR137 Locus.High-Throughput Assays to Assess the Functional Impact of Genetic Variants: A Road Towards Genomic-Driven Medicine.An analysis of possible off target effects following CAS9/CRISPR targeted deletions of neuropeptide gene enhancers from the mouse genome.Reward-related ventral striatum reactivity mediates gender-specific effects of a galanin remote enhancer haplotype on problem drinking.Plasma galanin is a biomarker for severity of major depressive disorder.Using mouse transgenic and human stem cell technologies to model genetic mutations associated with schizophrenia and autism.Applications of CRISPR/Cas9 in the Mammalian Central Nervous System.
P2860
Q26852735-09A36D4E-7C2E-4244-B94D-5436A4D1348BQ26991710-DF30A55A-103F-4DD8-92A1-AE074D181F87Q28822036-AB6A6D7F-3305-4584-B29B-1A27CF3C37E4Q31153726-E82A264A-9CF7-412E-B19E-69A2F9D65309Q34520815-63BBBBD3-E2A9-4461-B6A4-59B13185B7DDQ35307376-DF61614A-CB7D-45DB-B033-BA32D1EE0FF2Q35646774-4A17E9C9-A119-4738-AD20-78BDABCC22DCQ35921532-D3B688E2-F377-49E0-9944-D065D49798B3Q36210242-50FE0708-737B-4586-94D3-90AFF8BE3F64Q36213273-3DE45DFD-D0DC-42E4-A094-E999C3482D07Q36493625-433D6CE2-E9F0-4EEA-B17F-E6AB7A3BD26EQ36598124-86B98260-59D3-4AF6-9298-678A736D2C85Q36922331-974B2939-793B-4B2A-B645-4B9FF26C863AQ37015341-F15A150E-6E36-42A3-A59C-4ED4C1CA608DQ37150743-3DD36516-8169-45FB-8F6A-75D1022B5129Q37603928-15935ACF-0936-4DFA-8FD0-445E88C7FE32Q37606262-88F24C65-276D-4D2D-B3FB-94687151D6D1Q37725359-21535D85-1AD5-4888-AA8E-8D7E03EABA1AQ38212123-816EB3F5-E554-45ED-BEAA-A305B457288DQ38337093-4DD21239-56A6-4F79-8536-1FE82CF50B01Q38556483-420B5113-8A98-4F11-A35F-2BA01580361BQ38751829-345275DB-08D4-4812-A908-4AA14C5D429BQ39141707-42921707-86BD-49E2-97B6-C1AA21A97C52Q41139465-68ADFCAC-FB24-41D5-84F0-6BAB8B7C82B9Q48126816-1C4A3DED-BA34-4B3E-B8FC-CA20B7255974Q48179516-42DB4A24-3D39-4F5A-AA20-CEF24B29B377Q50418525-6AD5FF68-26A3-4C9E-9BA5-E752BB92E7BDQ52429670-05605198-0034-4004-9794-D73326CB88FE
P2860
Differential activity by polymorphic variants of a remote enhancer that supports galanin expression in the hypothalamus and amygdala: implications for obesity, depression and alcoholism
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Differential activity by polym ...... ity, depression and alcoholism
@ast
Differential activity by polym ...... ity, depression and alcoholism
@en
type
label
Differential activity by polym ...... ity, depression and alcoholism
@ast
Differential activity by polym ...... ity, depression and alcoholism
@en
prefLabel
Differential activity by polym ...... ity, depression and alcoholism
@ast
Differential activity by polym ...... ity, depression and alcoholism
@en
P2093
P2860
P50
P356
P1476
Differential activity by polym ...... ity, depression and alcoholism
@en
P2093
Alasdair MacKenzie
Amanda Baizan-Edge
Andrew Starkey
Benjamin Hing
Lynne Shanley
Marissa Lear
Perry Barrett
Peter McGuffin
Scott Davidson
P2860
P2888
P304
P356
10.1038/NPP.2011.93
P407
P577
2011-06-29T00:00:00Z
P5875
P6179
1011616631